All Posts: News Release
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release
-
Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers
Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins.
Category: News Release
-
Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the makeup of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early onset disease (age 45 or younger) or late-onset disease (age 65 or older).
Category: News Release
-
Georgetown Announces New Ralph Lauren Center for Cancer Prevention To Address Health Disparities in Washington, D.C.
Media Contact Karen Teberkm463@georgetown.edu WASHINGTON (April 10, 2023) — The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center will open on Mond
Category: News Release
-
$3.2 Million Grant Supports Study of New Genetic Testing Approach to Reduce Racial Health Disparities
The National Cancer Institute has awarded a $3.2 million grant to investigators from Georgetown University’s Lombardi Comprehensive Cancer Center and Rutgers Cancer Institute of New Jersey, both NCI-designated Comprehensive Cancer Centers, to examine a novel approach to genetic testing and care based on community-identified needs, with the aim of reducing racial disparity gaps in cancer care delivery.
Category: News Release
-
Study Finds Relationship Between Inconsistent Treatment and Frailty in Black Cancer Survivors
Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study.
Category: News Release
-
Ron Rivera, Washington Commanders’ Coach, to Receive NFL Players Association Georgetown Lombardi Award
WASHINGTON (January 5, 2023) — Georgetown University’s Lombardi Comprehensive Cancer Center and the NFL Players Association are pleased to announce Washington Commanders Coach and cancer survivor Ron Rivera as the recipient of the 2023 NFLPA Georgetown Lombardi Award. The annual award recognizes a sports figure who has faced cancer and who possesses the qualities that […]
Category: News Release
-
Drug Found to be Effective in Difficult to Treat Autoimmune Blood Disorder
Category: News Release
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
WASHINGTON (Thursday, December 1, 2022) — While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of […]
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
WASHINGTON (December 1, 2022) — In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast […]
Category: News Release